NIH-funded research R01 grant

Investigating how a virus can switch between latency and active infection

Official title: Studies on Viral Enhancer for Latency-Lytic Switch

Funded at University of California at Davis · NIH-11052059 · Data updated 2026-11-12

This study is looking at a virus that can cause certain cancers in people with HIV, and it aims to understand how the virus works in order to find new ways to treat these cancers, which could help improve care for patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California at Davis
NIH-funded
Lab location1 site (Davis, United States)
Project startJanuary 1, 2025
Project endDecember 31, 2029
Funding year2025
Award (this year)$564,698
NIH project number1R01CA290700-01A1
Project IDNIH-11052059 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals living with HIV who are at risk for or currently have KSHV-related malignancies.

Less likely to help

Patients who do not have HIV or KSHV-related cancers may not benefit from this research.

What this research studies

This research focuses on understanding the Kaposi’s sarcoma-associated herpesvirus (KSHV), which is linked to several cancers in HIV-positive individuals. The study aims to explore the 3D structure of the virus's genome and how it interacts with cellular factors to regulate gene expression. By identifying new drug targets, the research seeks to improve treatment options for patients suffering from KSHV-related malignancies. Patients may benefit from insights that could lead to more effective therapies for these cancers.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for cancers associated with HIV, improving patient outcomes.

How similar studies have gone: Previous research has shown promise in understanding viral gene regulation and its implications for cancer treatment, indicating potential for success in this area.

Where this research is happening

  • University of California at Davis
    Davis, United States
    Active

Researchers

  • Principal investigator: Izumiya, Yoshihiro — University of California at Davis
  • Study coordinator: Izumiya, Yoshihiro

Related research

Other NIH-funded projects on the same topics.

  • UC Davis IGA Innovation Center

    A research center at UC Davis will study gene-edited livestock to improve animal health, safety, and policy through sharing genetic data and findings about genome edits in cattle, pigs, sheep, and goats.

    NIH research University of California at Davis · Davis, United States · NIH-11641870

  • Administrative Core of an equitable breast cancer screening program

    A national program headed from UC Davis is coordinating several research efforts to improve how breast cancer screening is done in community settings.

    NIH research University of California at Davis · Davis, United States · NIH-11622111

  • The role of novelty and surprise in learning for people with Alzheimer’s disease

    A study explores how surprising events affect memory and learning in people related to Alzheimer’s disease, using everyday tasks to see how the brain remembers new information.

    NIH research University of California at Davis · Davis, United States · NIH-11617755

  • Understanding how distraction affects students and how to measure it better

    This grant studies why distracted students, including those with ADHD, struggle in real-life learning and tests a clearer way to measure distraction in everyday settings.

    NIH research University of California at Davis · Davis, United States · NIH-11617018

  • California Partnership for Personalized Nutrition

    A California clinical center is testing personalized dietary approaches to improve blood sugar and health for adults with diabetes by using big data and AI to tailor meals.

    NIH research University of California at Davis · Davis, United States · NIH-11605720

  • Advancing gastric cancer care for Latinos through patient-derived tumor models

    Aimed at Latinos with gastric cancer, this project uses patient-derived tumor models to study how cancer biology and treatments work in real tumors.

    NIH research University of California at Davis · Davis, United States · NIH-11603175

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.